5-methoxypsoralen has been researched along with Bone Loss, Osteoclastic in 2 studies
5-Methoxypsoralen: A linear furanocoumarin that has phototoxic and anti-inflammatory properties, with effects similar to METHOXSALEN. It is used in PUVA THERAPY for the treatment of PSORIASIS.
5-methoxypsoralen : A 5-methoxyfurocoumarin that is psoralen substituted by a methoxy group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G | 1 |
| Xu, Q | 1 |
| Dai, M | 1 |
| Liu, X | 1 |
| Zheng, M | 1 |
| Ge, Y | 1 |
| Li, H | 1 |
| Yan, M | 1 |
| Zhou, J | 1 |
| Zhang, Y | 1 |
2 other studies available for 5-methoxypsoralen and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Bergapten suppresses RANKL-induced osteoclastogenesis and ovariectomy-induced osteoporosis via suppression of NF-κB and JNK signaling pathways.
Topics: 5-Methoxypsoralen; Actins; Animals; Bone Density Conservation Agents; Bone Resorption; Female; Gene | 2019 |
Bergapten prevents lipopolysaccharide mediated osteoclast formation, bone resorption and osteoclast survival.
Topics: 5-Methoxypsoralen; Animals; Apoptosis; Bone Resorption; Caspase 3; Caspase 9; Cell Differentiation; | 2014 |